Nuovo Biologics is a biotechnology company focused on developing innovative biologic therapeutics, particularly in the fields of antiviral and oncology treatments. The company has established a strong foundation for research and development, leading to the formation of CYGNOS BioTech, LLC, which continues to pursue the development of nonspecific antiviral agents and oncology technologies. One of the key approaches adopted by the company is the 'One Health' paradigm, which emphasizes the interconnectedness of human and animal health, particularly in the context of zoonotic diseases. This perspective informs their research and development strategies, aiming to create therapeutics that can be effective across species.

Among their investigational products, Nuovo Biologics is developing PVX, a novel peptide derived from natural sources, which is being evaluated for its antiviral properties in non-food animals such as dogs, cats, horses, and birds. Preliminary studies indicate that PVX exhibits antiviral activity against a wide range of virus families. Additionally, the company is working on MMX, a formulation aimed at treating oral malignant melanoma in canines. In vitro studies have shown that MMX can inhibit the proliferation of melanoma cells, and clinical observations suggest significant tumor reduction in affected dogs. These efforts reflect Nuovo Biologics' commitment to advancing therapeutic options that benefit both animal and human health.

United States

Nuovo Biologics, LLC is a Florida based biotechnology company dedicated to research and development of the most innovative, safe and efficacious products such as drugs, biologicals, and supplements to best support and maximize animal health. Though the Company is focused on the animal market, it is performing translational research on products that can be applied to the human market.

Nuovo Biologics, LLC is dedicated to provide information sharing, training and education for clinical research and new product development promoting animal health and advocacy among all animal industry stakeholders.

Nuovo Biologics

Company Details